Treatment Registry
TR-0412 ActiveRecorded September 2, 2026

Unspecified GLP-1

Sold by Signos · every unspecified glp-1 record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$199

Medication · Signos+ GLP-1 + CGM plan (medication included), 3- or 6-month term$199

Added from the figures recorded below.

Price

TermPer monthCharged today
Signos+ GLP-1 + CGM plan (medication included), 3- or 6-month term

Don’t have a GLP‑1 yet? Signos+ ($199/mo) includes the medication →

source

Per month$199Charged today$199
Visit Signos

We earn nothing from this link. Signos has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

StatesAll 50 states
PrescriberAsynchronous review
Cancellation“You can cancel your auto-renewal by logging into your member portal or through the Signos app. Go to Account & Settings (tap the profile icon in the top left), then select Manage Subscription . Cancellations take effect at the end of your current billing cycle. Signos does not offer prorated refunds, and early cancellations on 3- or 6-month plans may be subject to a cancellation fee.”

Not yet checked: pharmacy, membership and consult fee.

Recorded from signos.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026Direct contradiction on the site about whether GLP-1 medication is offered at all: the general FAQ says 'Does the Signos membership include access to prescription medication? At this time, Signos does not offer any prescription medications or medical supplements.' (https://www.signos.com/faqs), while the /plans and /essentials pages market a dedicated 'Signos+ GLP‑1 Plans' product -- 'Clinician-prescribed GLP-1 + CGM,' 'Personalized 3 or 6-month GLP-1 treatment plan,' and 'Signos+ ($199/mo) includes the medication' -- fulfilled via OpenLoop Health clinicians and 'compounded GLP‑1 medications ... produced in FDA-registered facilities, but not FDA-approved.' Treated the dedicated GLP-1 pages as authoritative since they are more specific and current (2026 copyright), but this is a real, unresolved contradiction on the live site. The $199/mo figure's exact term (3 vs 6 months) is not stated on the page carrying the price, so term is left blank rather than guessed. Separately, Signos also sells 'GLP-1 Essentials' ($89/mo, https://www.signos.com/essentials) -- a CGM companion kit for people ALREADY on a GLP-1 elsewhere, explicitly 'Medication not included' -- this is excluded from prices per the membership-fee rule since Signos supplies no medication in that product. The general (non-GLP-1) Signos CGM subscription pricing is also inconsistently stated across pages ($127/$150/$225 per month on /plans vs $299/$199/$169 per month on /faqs) but that product is out of scope (no GLP-1) and not recorded here.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0412
Readings
1

Related records

Unspecified GLP-1 at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 72 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Signos unspecified GLP-1 (TR-0412). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0412

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.